Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.880
-0.050 (-2.59%)
At close: Jun 30, 2025, 4:00 PM
1.870
-0.010 (-0.53%)
After-hours: Jun 30, 2025, 7:54 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $88.57 million as of June 30, 2025. Its market cap has increased by 108.49% in one year.
Market Cap
88.57M
Enterprise Value
-142.50M
1-Year Change
108.49%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $88.57M, a decrease of -83.62%. That is a compound annual growth rate of -37.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 90.92M | 16.92% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |